page header

Analytics Link™

Unrivalled Coverage

Gain insights with a panoramic view of the rapidly evolving industry landscape, combined with the ability to drill down to individual drug therapies, companies and countries.

  • 6,700+ marketed drugs
  • 7,700+ active R&D projects
  • 335 Anatomical Therapeutic Category level 3 classes
  • The leading 350 pharmaceutical corporations
  • 71 countries including the key growth markets

Power Superior Decision Making and Enhance your Productivity

IMS Health Analytics Link seamlessly connects analysis and data for an extensive pharmaceutical universe of drugs, therapies, companies, countries, and diseases.

  • Drug: 6,700 leading marketed drugs
  • Therapy: 335 EphMRA level 3 therapy classes
  • Company: 350 leading companies
  • Country: 71 IMS Health audited countries
  • Query Builder: Define your own market segment

Connected Analysis for Better Performance

Connect the strategic insight of our analysts with a wealth of integrated data spanning sales, pipeline launch, loss of protection and deals intelligence.

For the first time, the deep granularity of MIDAS value and volume data is systematically complemented by company-reported sales and analyst consensus forecasts.

Add-On Modules for Deeper Insights

Interested in learning more about how QuintilesIMS’s Analytics LinkTM can help you succeed? Let us know how we can help you: